A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma

Gastroenterology

Volumn 125, Issue 2, 2003, Pages 364-371

  Machado, Jose Carlos ^a,b   Figueiredo, Céu ^a,c   Canedo, Paulo ^a,b   Pharoah, Paul ^d   Carvalho, Ralph ^a   Nabais, Sérgio ^a,b   Castro Alves, Catarina ^a,b   Campos, Maria Luisa ^a,b   Van Doorn, Leen Jan ^c   Caldas, Carlos ^d   Seruca, Raquel ^a,b   Carneiro, Fatima ^a,b,e   Sobrinho Simões, Manuel ^a,b,e  

^a UNIVERSITY OF PORTO   (Portugal)

^b Faculty of Medicine   (Portugal)

^c Delft Diagnostic Laboratory   (Netherlands)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CAGA PROTEIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

ADULT; AGED; ALLELE; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; CASE CONTROL STUDY; CHRONIC GASTRITIS; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE LOCUS; GENOTYPE; HELICOBACTER PYLORI; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TANDEM REPEAT;

EID: 0042667008     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00899-0     Document Type: Article

References (33)

1. Parkin DM. The global burden of cancer. Semin Cancer Biol 1998;8:219-235.
2. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131.
3. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - first American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-6740.
5. Sipponen P. Gastric cancer - a long-term consequence of Helicobacter pylori infection? Scand J Gastroenterol Suppl 1994;201:24-27.
6. Kuipers EJ, Uyterlinde AM, Pena AS, Roosendaal R, Pals G, Nelis GF, Festen HP, Meuwissen SG. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995;345:1525-1528.
7. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JFJ, Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer (published erratum appears in Nature 2001;412:99). Nature 2000;404:398-402.
8. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, Sobrinho-Simoes M. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001;121:823-829.
9. El-Omar EM. The importance of interleukin lbeta in Helicobacter pylori associated disease. Gut 2001;48:743-747.
10. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095-2147.
11. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994;29:425-429.
12. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998;16:27-55.
13. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473-1477.
14. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-lbeta production in vitro. Scand J Immunol 1998;47:195-198.
15. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, Yamaoka Y. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002;123:1793-1803.
16. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A Taql polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992;22:396-402.
17. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995;99:303-310.
18. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997;94:3195-3199.
19. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimurra H. Interleukin lbeta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002;123:92-105.
20. Zambon C, Basso D, Navaglia F, Germano G, Gallo N, Milazzo M, Greco E, Fogar P, Mazza S, Di Mario F, Basso G, Rugge M, Plebani M. Helicobacter pylori virulence genes and host IL-1RN and IL-1β genes interplay in favouring the development of peptic ulcer and intestinal metaplasia. Cytokine 2002;18:242-251.
21. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doorn LJ, Carneiro F, Sobrinho-Simões M. Helicobacter pylori and interleukin-1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002;94:1680-1687.
22. Lanas A, Garcia-Gonzalez MA, Santolaria S, Crusius JB, Serrano MT, Benito R, Pena AS. TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients. Genes Immun 2001;2:415-421.
23. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-1181.
24. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
25. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim Van Dillen PME, Van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495-503.
26. van Doorn LJ, Figueiredo C, Sanna R, Pena S, Midolo P, Ng EK, Atherton JC, Blaser MJ, Quint WG. Expanding allelic diversity of Helicobacter pylori vacA. J Clin Microbiol 1998;36:2597-2603.
27. van Doorn LJ, Figueiredo C, Rossau R, Jannes G, van Asbroek M, Sousa JC, Carneiro F, Quint WG. Typing of Helicobacter pylori vacA gene and detection of cagA gene by PCR and reverse hybridization. J Clin Microbiol 1998;36:1271-1276.
28. Dixon MF. Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol 1994;201(Suppl):7-10.
29. Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Br Med Bull 1998;54:139-150.
30. Kroeger KM, Steer JH, Joyce DA, Abraham LJ. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 2000;12:110-119.
31. Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 1998l;30:469-473.
32. Knight JC, Kwiatkowski D. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians 1999;111:290-298.
33. Solcia E, Fiocca R, Luinetti O, Villani L, Padovan L, Calistri D, Ranzani GN, Chiaravalli A, Capella C. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996;20(Suppl 1):S8-S22.